Experimental Covid-19 Treatment Puts Responsibility on Doctors

The South African Health Products Regulatory Authority (SAHPRA) has announced that doctors will be able to apply for access to the experimental COVID-19 treatment ivermectin in terms of section 21 of the Medicines Act. Section 21 is a mechanism that allows for access to medicines that SAHPRA has not yet approved. In allowing section 21 applications as part of a controlled compassionate access programme, SAHPRA has essentially shifted the responsibility for deciding whether the anti-parasitic ivermectin is safe and effective enough to be used in the treatment of COVID-19 to doctors. This places an enormous responsibility on doctors, since doctors who do decide to prescribe the drug will be responsible for any potential side effects.

InFocus

(file photo).

AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X